JP2005512522A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005512522A5 JP2005512522A5 JP2003538348A JP2003538348A JP2005512522A5 JP 2005512522 A5 JP2005512522 A5 JP 2005512522A5 JP 2003538348 A JP2003538348 A JP 2003538348A JP 2003538348 A JP2003538348 A JP 2003538348A JP 2005512522 A5 JP2005512522 A5 JP 2005512522A5
- Authority
- JP
- Japan
- Prior art keywords
- mut
- polypeptide
- nucleic acid
- drugs
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34371701P | 2001-10-26 | 2001-10-26 | |
| PCT/US2002/034381 WO2003035847A2 (en) | 2001-10-26 | 2002-10-25 | Il-13 mutein proteins, antibodies, compositions, methods and uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005512522A JP2005512522A (ja) | 2005-05-12 |
| JP2005512522A5 true JP2005512522A5 (https=) | 2006-01-05 |
Family
ID=23347323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003538348A Pending JP2005512522A (ja) | 2001-10-26 | 2002-10-25 | Ｉｌ−１３ムテインタンパク質、抗体、組成物、方法および使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040023337A1 (https=) |
| EP (1) | EP1578912A4 (https=) |
| JP (1) | JP2005512522A (https=) |
| CA (1) | CA2464695A1 (https=) |
| WO (1) | WO2003035847A2 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040234499A1 (en) * | 2001-10-26 | 2004-11-25 | David Shealy | Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses |
| HK1079882B (en) | 2002-06-14 | 2011-11-25 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treating and preventing colitis involving il-13 and nk-t cells |
| US20070104710A1 (en) * | 2002-06-28 | 2007-05-10 | Domants Limited | Ligand that has binding specificity for IL-4 and/or IL-13 |
| US20110223168A1 (en) * | 2002-12-27 | 2011-09-15 | Greg Winter | Ligand that has binding specificity for il-4 and/or il-13 |
| EP1444989A1 (en) * | 2003-02-07 | 2004-08-11 | Giorgio Dr. Stassi | Sensitizing cells for apoptosis by selectively blocking cytokines |
| KR101073590B1 (ko) * | 2003-07-15 | 2011-10-14 | 메디뮨 리미티드 | Ｉｌ-13에 대한 인간 항체 분자 |
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| SG10201404273QA (en) | 2003-12-23 | 2014-10-30 | Genentech Inc | Novel anti-il 13 antibodies and uses thereof |
| WO2005091853A2 (en) * | 2004-02-27 | 2005-10-06 | Centocor, Inc. | Methods and compositions for treating il-13 related pathologies |
| AR049390A1 (es) * | 2004-06-09 | 2006-07-26 | Wyeth Corp | Anticuerpos contra la interleuquina-13 humana y usos de los mismos |
| US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
| US20070048785A1 (en) * | 2004-06-09 | 2007-03-01 | Lin Laura L | Anti-IL-13 antibodies and complexes |
| JP2008520684A (ja) * | 2004-11-17 | 2008-06-19 | アブジェニックス・インコーポレーテッド | Ｉｌ−１３に対する完全ヒトモノクローナル抗体 |
| AU2006296399B2 (en) * | 2005-09-30 | 2011-01-20 | Medimmune Limited | Interleukin-13 antibody composition |
| RU2421464C2 (ru) | 2005-10-21 | 2011-06-20 | Новартис Аг | Человеческие антитела к il-13 и их терапевтическое применение |
| CA2656379A1 (en) * | 2006-06-21 | 2007-12-27 | Apogenix Gmbh | Differential cytokine expression in human cancer |
| AU2007271349A1 (en) * | 2006-07-06 | 2008-01-10 | Apogenix Gmbh | Human IL-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy |
| EP2050764A1 (en) | 2007-10-15 | 2009-04-22 | sanofi-aventis | Novel polyvalent bispecific antibody format and uses thereof |
| US8399630B2 (en) * | 2008-08-20 | 2013-03-19 | Centocor Ortho Biotech Inc. | Engineered anti-IL-13 antibodies, compositions, methods and uses |
| US9296785B2 (en) | 2009-04-17 | 2016-03-29 | Wake Forest University Health Sciences | IL-13 receptor binding peptides |
| JP2012526840A (ja) * | 2009-05-13 | 2012-11-01 | プロテイン デリヴァリー ソリューションズ エルエルシー | 膜貫通送達のための製剤系 |
| TWI732259B (zh) | 2010-12-16 | 2021-07-01 | 美商建南德克公司 | 關於th2抑制作用之診斷及治療 |
| US20130344074A1 (en) | 2011-03-16 | 2013-12-26 | Sanofi | Uses of a dual v region antibody-like protein |
| TWI679019B (zh) | 2013-04-29 | 2019-12-11 | 法商賽諾菲公司 | 抗ｉｌ－４／抗ｉｌ－１３之雙特異性抗體調配物 |
| EP4331605A3 (en) | 2013-09-13 | 2024-05-22 | F. Hoffmann-La Roche AG | Methods and compositions comprising purified recombinant polypeptides |
| ES2915378T3 (es) | 2013-09-13 | 2022-06-22 | Hoffmann La Roche | Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares |
| EP3129497B1 (en) | 2014-04-11 | 2021-09-08 | Novartis AG | Methods of selectively treating asthma using il-13 antagonists |
| TW201628647A (zh) | 2014-06-27 | 2016-08-16 | 賽諾菲公司 | 抗－ｉｌ４－ｉｌ１３雙特異性抗體 |
| CN113101364B (zh) | 2018-05-29 | 2023-12-01 | 康诺亚生物医药科技（成都）有限公司 | 一种自免疫抑制剂的开发和应用 |
| WO2020242989A1 (en) | 2019-05-24 | 2020-12-03 | Sanofi | Methods for treating systemic sclerosis |
| WO2021097327A1 (en) * | 2019-11-13 | 2021-05-20 | University Of Virginia Patent Foundation | Treatment of clostridium difficile infections |
| WO2022122654A1 (en) | 2020-12-07 | 2022-06-16 | UCB Biopharma SRL | Multi-specific antibodies and antibody combinations |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000044407A2 (en) * | 1999-02-01 | 2000-08-03 | Amgen Canada | Materials and methods to inhibit hodgkin and reed sternberg cell growth |
| US20040219149A1 (en) * | 2001-06-08 | 2004-11-04 | Yuhong Zhou | Methods for the modulation of il-13 |
| WO2001008660A2 (en) * | 1999-08-02 | 2001-02-08 | The Regents Of The University Of Michigan | Targeted fiberless radiative effectors |
-
2002
- 2002-10-25 US US10/280,645 patent/US20040023337A1/en not_active Abandoned
- 2002-10-25 JP JP2003538348A patent/JP2005512522A/ja active Pending
- 2002-10-25 WO PCT/US2002/034381 patent/WO2003035847A2/en not_active Ceased
- 2002-10-25 EP EP02793830A patent/EP1578912A4/en not_active Withdrawn
- 2002-10-25 CA CA002464695A patent/CA2464695A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005512522A5 (https=) | ||
| JP2007508011A5 (https=) | ||
| AU2002324625B2 (en) | Interleukin-1 receptors in the treatment of diseases | |
| JP2015522590A (ja) | 標的化治療薬 | |
| ES2680222T3 (es) | Modulación de los receptores con dominio Vps10p para el tratamiento de la enfermedad cardiovascular | |
| JP2003509378A (ja) | ＩＬ−１ｒａとＩＬ−１プロセシング・放出阻害化合物の併用療法 | |
| JP2012506695A5 (https=) | ||
| JP6921755B2 (ja) | 脳腫瘍幹細胞の成長、遊走および浸潤性を低下させ脳腫瘍患者の生存率を改善する方法および組成物 | |
| HRP20140982T1 (hr) | Ljudska anti-il-23 antitijela, pripravci, postupci i upotrebe | |
| CN103459595B (zh) | 针对人前列腺素e2受体ep4的抗体 | |
| KR20210132749A (ko) | 염증성 질환에서 il-18 결합 단백질(ｉｌ-18ｂｐ) | |
| JP2008525477A5 (https=) | ||
| TW200529853A (en) | Method of treatment of transplant rejection | |
| EP1575511A2 (en) | A new target for angiogenesis and anti-angiogenesis therapy | |
| JP2010534664A5 (https=) | ||
| CA2609349A1 (en) | Anti-mcp-1 antibodies, compositions, methods and uses | |
| JP2011517548A5 (https=) | ||
| CN111417647A (zh) | 新型senolytic肽 | |
| JP2022536289A (ja) | 抗炎症剤 | |
| TW202237634A (zh) | 用於治療ｃｏｖｉｄ－１９之ｄｓｇ２組成物和方法 | |
| US8101580B2 (en) | Therapeutic agent for irritable bowel syndrome | |
| EP4144364A1 (en) | Method and drug for treating spinal muscular atrophy | |
| KR20150070180A (ko) | 근위축성 측삭 경화증 치료제 | |
| JP2023523568A (ja) | ＡｃｔＲＩＩＢリガンドトラップ及びフェドラチニブを使用して貧血を治療するための方法 | |
| CN102741277A (zh) | 在治疗运动神经元疾病中的IFNγ抑制剂 |